FDA to Keep Reviewing Risky Medical Products during Shutdown

January 2, 2019

The Food and Drug Administration (FDA) will continue to review potentially risky medical products imported into the U.S. during the partial government shutdown, according to agency Commissioner Scott Gottlieb, M.D.

Related Stories